Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept.

Chen W, Barback CV, Wang S, Hoh CK, Chang EY, Hall DJ, Head BP, Vera DR.

Nucl Med Biol. 2020 Mar 5. pii: S0969-8051(20)30003-2. doi: 10.1016/j.nucmedbio.2020.02.013. [Epub ahead of print]

PMID:
32169304
2.

Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept.

Qin Z, Hoh CK, Olson ES, Jahromi AH, Hall DJ, Barback CV, You YH, Yanagita M, Sharma K, Vera DR.

J Nucl Med. 2019 Sep;60(9):1325-1332. doi: 10.2967/jnumed.118.223727. Epub 2019 Feb 22.

3.

Next generation of radiotracers for sentinel lymph node biopsy: What is still necessary to establish new imaging paradigms?

Vidal-Sicart S, Vera DR, Valdés Olmos RA.

Rev Esp Med Nucl Imagen Mol. 2018 Nov - Dec;37(6):373-379. doi: 10.1016/j.remn.2018.09.001. Epub 2018 Nov 5. English, Spanish.

PMID:
30409688
4.

Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model.

Anderson KM, Barback CV, Qin Z, Hall DJ, Hoh CK, Vera DR, McHale MT.

PLoS One. 2018 Jul 2;13(7):e0197842. doi: 10.1371/journal.pone.0197842. eCollection 2018.

5.

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept.

Varasteh Z, Hyafil F, Anizan N, Diallo D, Aid-Launais R, Mohanta S, Li Y, Braeuer M, Steiger K, Vigne J, Qin Z, Nekolla SG, Fabre JE, Döring Y, Le Guludec D, Habenicht A, Vera DR, Schwaiger M.

EJNMMI Res. 2017 Dec;7(1):40. doi: 10.1186/s13550-017-0287-y. Epub 2017 May 3.

6.

Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes.

Lee HJ, Barback CV, Hoh CK, Qin Z, Kader K, Hall DJ, Vera DR, Kane CJ.

J Nucl Med. 2017 Apr;58(4):547-553. doi: 10.2967/jnumed.116.178582. Epub 2017 Feb 2.

7.

New Dioxaborolane Chemistry Enables [(18)F]-Positron-Emitting, Fluorescent [(18)F]-Multimodality Biomolecule Generation from the Solid Phase.

Rodriguez EA, Wang Y, Crisp JL, Vera DR, Tsien RY, Ting R.

Bioconjug Chem. 2016 May 18;27(5):1390-1399. doi: 10.1021/acs.bioconjchem.6b00164. Epub 2016 Apr 27.

8.

Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models.

Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR.

Nucl Med Biol. 2016 Feb;43(2):179-87. doi: 10.1016/j.nucmedbio.2015.11.009. Epub 2015 Dec 2.

PMID:
26872443
9.

A tri-modal molecular imaging agent for sentinel lymph node mapping.

Qin Z, Hoh CK, Hall DJ, Vera DR.

Nucl Med Biol. 2015 Dec;42(12):917-22. doi: 10.1016/j.nucmedbio.2015.07.011. Epub 2015 Jul 31.

10.

Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy.

Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S559-65. doi: 10.1245/s10434-015-4802-y. Epub 2015 Aug 15.

11.

γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206).

Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera DR, Schlesinger LS.

J Immunol. 2015 Sep 1;195(5):2019-29. doi: 10.4049/jimmunol.1402005. Epub 2015 Jul 22.

12.

Sentinel lymph node biopsy in bladder cancer: Systematic review and technology update.

Liss MA, Noguchi J, Lee HJ, Vera DR, Kader AK.

Indian J Urol. 2015 Jul-Sep;31(3):170-5. doi: 10.4103/0970-1591.159601. Review.

13.

Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model.

Liss MA, Stroup SP, Qin Z, Hoh CK, Hall DJ, Vera DR, Kane CJ.

Urology. 2014 Oct;84(4):982.e9-14. doi: 10.1016/j.urology.2014.06.021. Epub 2014 Aug 16.

14.

A hybrid solid-fluorous phase radioiodination and purification platform.

Dzandzi JP, Vera DR, Valliant JF.

J Labelled Comp Radiopharm. 2014 Jul;57(9):551-7. doi: 10.1002/jlcr.3214. Epub 2014 Jul 28.

PMID:
25069901
15.

Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.

Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, Wallace AM.

Ann Surg Oncol. 2015 Jan;22(1):40-5. doi: 10.1245/s10434-014-3892-2. Epub 2014 Jul 29.

16.

Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging.

Liss MA, Farshchi-Heydari S, Qin Z, Hickey SA, Hall DJ, Kane CJ, Vera DR.

J Nucl Med. 2014 Sep;55(9):1552-6. doi: 10.2967/jnumed.114.140871. Epub 2014 Jul 14.

17.

Fluorescent-tilmanocept for tumor margin analysis in the mouse model.

Hosseini A, Baker JL, Tokin CA, Qin Z, Hall DJ, Stupak DG, Hayashi T, Wallace AM, Vera DR.

J Surg Res. 2014 Aug;190(2):528-34. doi: 10.1016/j.jss.2014.05.012. Epub 2014 May 10.

18.

Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom.

Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, Vera DR, Balkay L.

Phys Med Biol. 2014 Jun 7;59(11):2727-46. doi: 10.1088/0031-9155/59/11/2727. Epub 2014 May 6.

PMID:
24800813
19.

68Ga chelating bioorthogonal tetrazine polymers for the multistep labeling of cancer biomarkers.

Nichols B, Qin Z, Yang J, Vera DR, Devaraj NK.

Chem Commun (Camb). 2014 May 25;50(40):5215-5217. doi: 10.1039/c3cc49530b. Epub 2014 Mar 4.

20.

Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.

Barta P, Laznickova A, Laznicek M, Vera DR, Beran M.

J Labelled Comp Radiopharm. 2013 May 15;56(5):280-8. doi: 10.1002/jlcr.2988. Epub 2013 Jan 30.

PMID:
24285372
21.

Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes.

Qin Z, Hall DJ, Liss MA, Hoh CK, Kane CJ, Wallace AM, Vera DR.

J Biomed Opt. 2013 Oct;18(10):101315. doi: 10.1117/1.JBO.18.10.101315.

22.

Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells.

Liberman A, Wu Z, Barback CV, Viveros R, Blair SL, Ellies LG, Vera DR, Mattrey RF, Kummel AC, Trogler WC.

ACS Nano. 2013 Jul 23;7(7):6367-77. doi: 10.1021/nn402507d. Epub 2013 Jul 1.

23.

Development of ⁶⁸Ga-labelled DTPA galactosyl human serum albumin for liver function imaging.

Haubner R, Vera DR, Farshchi-Heydari S, Helbok A, Rangger C, Putzer D, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1245-55. doi: 10.1007/s00259-013-2397-8. Epub 2013 Apr 12.

PMID:
23579865
24.

Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.

Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR.

Ann Surg Oncol. 2013 Aug;20(8):2590-9. doi: 10.1245/s10434-013-2887-8. Epub 2013 Mar 17.

25.

A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging.

Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera DR.

Radiology. 2012 Oct;265(1):186-93. Epub 2012 Jul 2.

26.

The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care.

Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, Hartman RD, Joy MT, King DW, Christman LA, Vera DR, Wallace AM.

Clin Exp Metastasis. 2012 Oct;29(7):681-6. doi: 10.1007/s10585-012-9497-x. Epub 2012 Jun 23. Review.

PMID:
22729510
27.

Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model.

Stroup SP, Kane CJ, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera DR.

Clin Exp Metastasis. 2012 Oct;29(7):673-80. doi: 10.1007/s10585-012-9498-9. Epub 2012 Jun 20.

PMID:
22714690
28.

Imaging of protein synthesis: in vitro and in vivo evaluation of (44)Sc-DOTA-puromycin.

Eigner S, Vera DR, Fellner M, Loktionova NS, Piel M, Lebeda O, Rösch F, Roß TL, Henke KE.

Mol Imaging Biol. 2013 Feb;15(1):79-86. doi: 10.1007/s11307-012-0561-3.

PMID:
22565849
29.

Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors.

Vera DR, Eigner S, Henke KE, Lebeda O, Melichar F, Beran M.

Nucl Med Biol. 2012 Jan;39(1):3-13. doi: 10.1016/j.nucmedbio.2011.07.001. Epub 2011 Sep 29.

PMID:
21958849
30.

Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors.

Vera DR, Eigner S, Beran M, Henke KE, Laznickova A, Laznicek M, Melichar F, Chinol M.

Cancer Biother Radiopharm. 2011 Jun;26(3):287-97. doi: 10.1089/cbr.2010.0916. Epub 2011 Jun 28.

PMID:
21711096
31.

99mTc-Diethylenetriaminepentaacetic acid-mannosyl-dextran.

Cheng KT, Vera DR, Wallace AM, Hoh CK, Mendez J, Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Oct 23 [updated 2011 Mar 2].

32.

Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes.

Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera DR, Tsien RY.

Bioconjug Chem. 2010 Oct 20;21(10):1811-9. doi: 10.1021/bc1001328.

33.

Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol.

Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR.

Nucl Med Biol. 2009 Aug;36(6):687-92. doi: 10.1016/j.nucmedbio.2009.04.007.

34.

mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.

Shackelford DB, Vasquez DS, Corbeil J, Wu S, Leblanc M, Wu CL, Vera DR, Shaw RJ.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11137-42. doi: 10.1073/pnas.0900465106. Epub 2009 Jun 18.

35.

Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function.

Wu W, Kitamura S, Truong DM, Rieg T, Vallon V, Sakurai H, Bush KT, Vera DR, Ross RS, Nigam SK.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F210-7. doi: 10.1152/ajprenal.90260.2008. Epub 2009 May 13.

36.

Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek.

Wallace AM, Hoh CK, Darrah DD, Schulteis G, Vera DR.

Nucl Med Biol. 2007 Oct;34(7):849-53. Epub 2007 Aug 9.

37.
38.

Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET.

Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK.

Nucl Med Commun. 2007 Jan;28(1):7-13.

PMID:
17159543
39.

Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping.

Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR.

Ann Surg Oncol. 2007 Feb;14(2):913-21. Epub 2006 Dec 5.

PMID:
17146742
40.

Molecular targeting of the lymphovascular system for imaging and therapy.

Schöder H, Glass EC, Pecking AP, Harness JK, Wallace AM, Hirnle P, Alberini JL, Vilain D, Larson SM, Hoh CK, Vera DR.

Cancer Metastasis Rev. 2006 Jun;25(2):185-201. Review.

PMID:
16770532
41.

Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek.

Wallace AM, Ellner SJ, Méndez J, Hoh CK, Salem CE, Bosch CM, Orahood RC, Vera DR.

Surgery. 2006 Feb;139(2):217-23.

PMID:
16455331
42.
43.

Breast imaging: a surgeon's prospective.

Wallace AM, Comstock C, Hoh CK, Vera DR.

Nucl Med Biol. 2005 Oct;32(7):781-92.

PMID:
16243654
44.

What is to be gained by imaging the same animal before and after treatment?

Scheibe PO, Vera DR, Eckelman WC.

Nucl Med Biol. 2005 Oct;32(7):727-32. Erratum in: Nucl Med Biol. 2006 Jan;33(1):3.

PMID:
16243648
45.

Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry.

Vera DR, Hall DJ, Hoh CK, Gallant P, McIntosh LM, Mattrey RF.

Nucl Med Biol. 2005 Oct;32(7):687-93.

PMID:
16243643
46.

Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic?

Eckelman WC, Rohatagi S, Krohn KA, Vera DR.

Nucl Med Biol. 2005 Oct;32(7):657-62.

PMID:
16243639
47.

Radiation doses in the surroundings of patients undergoing nuclear medicine diagnostic studies.

Gomez-Palacios M, Terrón JA, Domínguez P, Vera DR, Osuna RF.

Health Phys. 2005 Aug;89(2 Suppl):S27-34.

PMID:
16010116
48.

Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.

Sirlin CB, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF.

Acad Radiol. 2004 Dec;11(12):1361-9.

PMID:
15596374
49.

Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model.

Ellner SJ, Méndez J, Vera DR, Hoh CK, Ashburn WL, Wallace AM.

Ann Surg Oncol. 2004 Jul;11(7):674-81.

PMID:
15231522
50.

Clinical application of TcGSA.

Kokudo N, Vera DR, Makuuchi M.

Nucl Med Biol. 2003 Nov;30(8):845-9. Review.

PMID:
14698788

Supplemental Content

Support Center